▶ 調査レポート

粗ヘパリンの世界及び中国市場

• 英文タイトル:Global and China Crude Heparin Market Insights, Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。粗ヘパリンの世界及び中国市場 / Global and China Crude Heparin Market Insights, Forecast to 2027 / QY2108PAL8802資料のイメージです。• レポートコード:QY2108PAL8802
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、148ページ
• 納品方法:Eメール(納期:1日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の当調査資料ではグローバルにおける粗ヘパリンの市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、粗ヘパリンの種類別市場規模(豚腸粘膜ヘパリン、牛ヘパリン、その他)、用途別市場規模(未分画ヘパリン(UFH)、低分子量ヘパリン(LMWH))も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界の粗ヘパリン市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界における粗ヘパリンの種類別市場規模(2016年-2027年):豚腸粘膜ヘパリン、牛ヘパリン、その他
・世界における粗ヘパリンの用途別市場規模(2016年-2027年):未分画ヘパリン(UFH)、低分子量ヘパリン(LMWH)
・粗ヘパリンの中国市場分析
- 粗ヘパリンの中国市場規模(2016年-2027年)
- 中国における粗ヘパリンの主要プレイヤー別市場シェア
- 中国における粗ヘパリンの種類別市場規模:豚腸粘膜ヘパリン、牛ヘパリン、その他
- 中国における粗ヘパリンの用途別市場規模:未分画ヘパリン(UFH)、低分子量ヘパリン(LMWH)
・粗ヘパリンの北米市場(2016年-2027年)
・粗ヘパリンのヨーロッパ市場(2016年-2027年)
・粗ヘパリンのアジア太平洋市場(2016年-2027年)
・粗ヘパリンの中南米市場(2016年-2027年)
・粗ヘパリンの中東・アフリカ市場(2016年-2027年)
・主要プレイヤーの情報:Bioiberica、Shenzhen Hepalink、Sanofi、Nanjing King-friend、Fengrun Biological Technology、Aspen Oss、Hebei Changshan Biochemical、Changzhou Qianhong、Hepac (Darling Ingredients)、Huaian MDC Pharmaceutical、Yantai Dongcheng Biochemicals
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...

Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916.
Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines.
Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
The Top 5 manufacturers, Bioiberica, Shenzhen Hepalink, Nanjing King-friend, Sanofi and Fengrun Biological, held 56.28% of the market, in terms of revenue in 2019.

Market Analysis and Insights: Global and China Crude Heparin Market
This report focuses on global and China Crude Heparin market.
In 2020, the global Crude Heparin market size was US$ 3585.3 million and it is expected to reach US$ 6466.7 million by the end of 2027, with a CAGR of 8.8% during 2021-2027. In China the Crude Heparin market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Crude Heparin Scope and Market Size
Crude Heparin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Crude Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Crude Heparin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Pig intestine mucosa heparin is almost the only used and efficient type, taking 99.47% market share in 2019, in terms of volume.

Segment by Application
Unfractionated Heparin (UFH)
Low-Molecular-Weight Heparin (LMWH)
LMWH is the largest consumer group, with market share of 89.03% in 2019, in terms of volume.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals

レポート目次

1 Study Coverage
1.1 Crude Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Crude Heparin Market Size Growth Rate by Type
1.2.2 Pig Intestine Mucosa Heparin
1.2.3 Bovine Heparin and Others
1.3 Market by Application
1.3.1 Global Crude Heparin Market Size Growth Rate by Application
1.3.2 Unfractionated Heparin (UFH)
1.3.3 Low-Molecular-Weight Heparin (LMWH)
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Crude Heparin Market Size, Estimates and Forecasts
2.1.1 Global Crude Heparin Revenue 2016-2027
2.1.2 Global Crude Heparin Sales 2016-2027
2.2 Global Crude Heparin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Crude Heparin Historical Market Size by Region (2016-2021)
2.3.1 Global Crude Heparin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Crude Heparin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Crude Heparin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Crude Heparin Sales Forecast by Region (2022-2027)
2.4.2 Global Crude Heparin Revenue Forecast by Region (2022-2027)

3 Global Crude Heparin Competitor Landscape by Players
3.1 Global Top Crude Heparin Manufacturers by Sales
3.1.1 Global Crude Heparin Sales by Manufacturer (2016-2021)
3.1.2 Global Crude Heparin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Crude Heparin Manufacturers by Revenue
3.2.1 Key Crude Heparin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Crude Heparin Revenue by Manufacturers (2016-2021)
3.2.3 Global Crude Heparin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Crude Heparin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Crude Heparin Revenue in 2020
3.2.6 Global Crude Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Crude Heparin Price by Manufacturers
3.4 Global Crude Heparin Manufacturing Base Distribution, Product Types
3.4.1 Crude Heparin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Crude Heparin Product Type
3.4.3 Date of International Manufacturers Enter into Crude Heparin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Crude Heparin Market Size by Type (2016-2021)
4.1.1 Global Crude Heparin Sales by Type (2016-2021)
4.1.2 Global Crude Heparin Revenue by Type (2016-2021)
4.1.3 Crude Heparin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Crude Heparin Market Size Forecast by Type (2022-2027)
4.2.1 Global Crude Heparin Sales Forecast by Type (2022-2027)
4.2.2 Global Crude Heparin Revenue Forecast by Type (2022-2027)
4.2.3 Crude Heparin Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Crude Heparin Market Size by Application (2016-2021)
5.1.1 Global Crude Heparin Sales by Application (2016-2021)
5.1.2 Global Crude Heparin Revenue by Application (2016-2021)
5.1.3 Crude Heparin Price by Application (2016-2021)
5.2 Crude Heparin Market Size Forecast by Application (2022-2027)
5.2.1 Global Crude Heparin Sales Forecast by Application (2022-2027)
5.2.2 Global Crude Heparin Revenue Forecast by Application (2022-2027)
5.2.3 Global Crude Heparin Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Crude Heparin Market Size YoY Growth 2016-2027
6.1.1 China Crude Heparin Sales YoY Growth 2016-2027
6.1.2 China Crude Heparin Revenue YoY Growth 2016-2027
6.1.3 China Crude Heparin Market Share in Global Market 2016-2027
6.2 China Crude Heparin Market Size by Players (International and Local Players)
6.2.1 China Top Crude Heparin Players by Sales (2016-2021)
6.2.2 China Top Crude Heparin Players by Revenue (2016-2021)
6.3 China Crude Heparin Historic Market Review by Type (2016-2021)
6.3.1 China Crude Heparin Sales Market Share by Type (2016-2021)
6.3.2 China Crude Heparin Revenue Market Share by Type (2016-2021)
6.3.3 China Crude Heparin Price by Type (2016-2021)
6.4 China Crude Heparin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Crude Heparin Sales Forecast by Type (2022-2027)
6.4.2 China Crude Heparin Revenue Forecast by Type (2022-2027)
6.4.3 China Crude Heparin Price Forecast by Type (2022-2027)
6.5 China Crude Heparin Historic Market Review by Application (2016-2021)
6.5.1 China Crude Heparin Sales Market Share by Application (2016-2021)
6.5.2 China Crude Heparin Revenue Market Share by Application (2016-2021)
6.5.3 China Crude Heparin Price by Application (2016-2021)
6.6 China Crude Heparin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Crude Heparin Sales Forecast by Application (2022-2027)
6.6.2 China Crude Heparin Revenue Forecast by Application (2022-2027)
6.6.3 China Crude Heparin Price Forecast by Application (2022-2027)

7 North America
7.1 North America Crude Heparin Market Size YoY Growth 2016-2027
7.2 North America Crude Heparin Market Facts & Figures by Country
7.2.1 North America Crude Heparin Sales by Country (2016-2021)
7.2.2 North America Crude Heparin Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Crude Heparin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Crude Heparin Market Facts & Figures by Region
8.2.1 Asia Pacific Crude Heparin Sales by Region (2016-2021)
8.2.2 Asia Pacific Crude Heparin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Crude Heparin Market Size YoY Growth 2016-2027
9.2 Europe Crude Heparin Market Facts & Figures by Country
9.2.1 Europe Crude Heparin Sales by Country (2016-2021)
9.2.2 Europe Crude Heparin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Crude Heparin Market Size YoY Growth 2016-2027
10.2 Latin America Crude Heparin Market Facts & Figures by Country
10.2.1 Latin America Crude Heparin Sales by Country (2016-2021)
10.2.2 Latin America Crude Heparin Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Crude Heparin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Crude Heparin Market Facts & Figures by Country
11.2.1 Middle East and Africa Crude Heparin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Crude Heparin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Bioiberica
12.1.1 Bioiberica Corporation Information
12.1.2 Bioiberica Description and Business Overview
12.1.3 Bioiberica Crude Heparin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bioiberica Crude Heparin Products Offered
12.1.5 Bioiberica Recent Development
12.2 Shenzhen Hepalink
12.2.1 Shenzhen Hepalink Corporation Information
12.2.2 Shenzhen Hepalink Description and Business Overview
12.2.3 Shenzhen Hepalink Crude Heparin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Shenzhen Hepalink Crude Heparin Products Offered
12.2.5 Shenzhen Hepalink Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Description and Business Overview
12.3.3 Sanofi Crude Heparin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Crude Heparin Products Offered
12.3.5 Sanofi Recent Development
12.4 Nanjing King-friend
12.4.1 Nanjing King-friend Corporation Information
12.4.2 Nanjing King-friend Description and Business Overview
12.4.3 Nanjing King-friend Crude Heparin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Nanjing King-friend Crude Heparin Products Offered
12.4.5 Nanjing King-friend Recent Development
12.5 Fengrun Biological Technology
12.5.1 Fengrun Biological Technology Corporation Information
12.5.2 Fengrun Biological Technology Description and Business Overview
12.5.3 Fengrun Biological Technology Crude Heparin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Fengrun Biological Technology Crude Heparin Products Offered
12.5.5 Fengrun Biological Technology Recent Development
12.6 Aspen Oss
12.6.1 Aspen Oss Corporation Information
12.6.2 Aspen Oss Description and Business Overview
12.6.3 Aspen Oss Crude Heparin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Aspen Oss Crude Heparin Products Offered
12.6.5 Aspen Oss Recent Development
12.7 Hebei Changshan Biochemical
12.7.1 Hebei Changshan Biochemical Corporation Information
12.7.2 Hebei Changshan Biochemical Description and Business Overview
12.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hebei Changshan Biochemical Crude Heparin Products Offered
12.7.5 Hebei Changshan Biochemical Recent Development
12.8 Changzhou Qianhong
12.8.1 Changzhou Qianhong Corporation Information
12.8.2 Changzhou Qianhong Description and Business Overview
12.8.3 Changzhou Qianhong Crude Heparin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Changzhou Qianhong Crude Heparin Products Offered
12.8.5 Changzhou Qianhong Recent Development
12.9 Hepac (Darling Ingredients)
12.9.1 Hepac (Darling Ingredients) Corporation Information
12.9.2 Hepac (Darling Ingredients) Description and Business Overview
12.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hepac (Darling Ingredients) Crude Heparin Products Offered
12.9.5 Hepac (Darling Ingredients) Recent Development
12.10 Huaian MDC Pharmaceutical
12.10.1 Huaian MDC Pharmaceutical Corporation Information
12.10.2 Huaian MDC Pharmaceutical Description and Business Overview
12.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Huaian MDC Pharmaceutical Crude Heparin Products Offered
12.10.5 Huaian MDC Pharmaceutical Recent Development
12.11 Bioiberica
12.11.1 Bioiberica Corporation Information
12.11.2 Bioiberica Description and Business Overview
12.11.3 Bioiberica Crude Heparin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bioiberica Crude Heparin Products Offered
12.11.5 Bioiberica Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Crude Heparin Industry Trends
13.2 Crude Heparin Market Drivers
13.3 Crude Heparin Market Challenges
13.4 Crude Heparin Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Crude Heparin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Crude Heparin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Pig Intestine Mucosa Heparin
Table 3. Major Manufacturers of Bovine Heparin and Others
Table 4. Global Crude Heparin Market Size Growth Rate by Application (2021-2027) & (MT)
Table 5. Global Crude Heparin Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Crude Heparin Sales by Regions (2016-2021) & (MT)
Table 7. Global Crude Heparin Sales Market Share by Regions (2016-2021)
Table 8. Global Crude Heparin Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Crude Heparin Sales Forecast by Region (2022-2027) & (MT)
Table 10. Global Crude Heparin Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Crude Heparin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Crude Heparin Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Crude Heparin Sales by Manufacturers (2016-2021) (MT)
Table 14. Global Crude Heparin Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Crude Heparin Manufacturers by Revenue (US$ Million) in 2020
Table 16. Crude Heparin Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Crude Heparin Revenue Share by Manufacturers (2016-2021)
Table 18. Global Crude Heparin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Crude Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crude Heparin as of 2020)
Table 20. Key Manufacturers Crude Heparin Price (2016-2021) (USD/Kg)
Table 21. Crude Heparin Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Crude Heparin Product Type
Table 23. Date of International Manufacturers Enter into Crude Heparin Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Crude Heparin Sales by Type (2016-2021) (MT)
Table 26. Global Crude Heparin Sales Share by Type (2016-2021)
Table 27. Global Crude Heparin Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Crude Heparin Revenue Share by Type (2016-2021)
Table 29. Crude Heparin Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 30. Global Crude Heparin Sales Forecast by Type (2022-2027) & (MT)
Table 31. Global Crude Heparin Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Crude Heparin Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Crude Heparin Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Crude Heparin Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 35. Global Crude Heparin Sales by Application (2016-2021) (MT)
Table 36. Global Crude Heparin Sales Share by Application (2016-2021)
Table 37. Global Crude Heparin Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Crude Heparin Revenue Share by Application (2016-2021)
Table 39. Crude Heparin Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 40. Global Crude Heparin Sales Forecast by Application (2022-2027) & (MT)
Table 41. Global Crude Heparin Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Crude Heparin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Crude Heparin Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Crude Heparin Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 45. China Crude Heparin Sales (MT) of Key Companies (2016-2021)
Table 46. China Crude Heparin Sales Share by Company (2016-2021)
Table 47. China Crude Heparin Revenue (US$ Million) by Company (2016-2021)
Table 48. China Crude Heparin Revenue Share by Company (2016-2021)
Table 49. China Crude Heparin Sales (MT) by Type (2016-2021)
Table 50. China Crude Heparin Sales Share by Type (2016-2021)
Table 51. China Crude Heparin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Crude Heparin Price (USD/Kg) by Type (2016-2021)
Table 53. China Crude Heparin Sales (MT) by Type (2022-2027)
Table 54. China Crude Heparin Sales Share by Type (2022-2027)
Table 55. China Crude Heparin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Crude Heparin Revenue Share by Type (2022-2027)
Table 57. China Crude Heparin Price (USD/Kg) by Type (2022-2027)
Table 58. China Crude Heparin Sales (MT) by Application (2016-2021)
Table 59. China Crude Heparin Sales Share by Application (2016-2021)
Table 60. China Crude Heparin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Crude Heparin Price (USD/Kg) by Application (2016-2021)
Table 62. China Crude Heparin Sales (MT) by Application (2022-2027)
Table 63. China Crude Heparin Sales Share by Application (2022-2027)
Table 64. China Crude Heparin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Crude Heparin Revenue Share by Application (2022-2027)
Table 66. China Crude Heparin Price (USD/Kg) by Application (2022-2027)
Table 67. North America Crude Heparin Sales by Country (2016-2021) & (MT)
Table 68. North America Crude Heparin Sales Market Share by Country (2016-2021)
Table 69. North America Crude Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Crude Heparin Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Crude Heparin Sales by Region (2016-2021) & (MT)
Table 72. Asia Pacific Crude Heparin Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Crude Heparin Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Crude Heparin Revenue Market Share by Region (2016-2021)
Table 75. Europe Crude Heparin Sales by Country (2016-2021) & (MT)
Table 76. Europe Crude Heparin Sales Market Share by Country (2016-2021)
Table 77. Europe Crude Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Crude Heparin Revenue Market Share by Country (2016-2021)
Table 79. Latin America Crude Heparin Sales by Country (2016-2021) & (MT)
Table 80. Latin America Crude Heparin Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Crude Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Crude Heparin Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Crude Heparin Sales by Country (2016-2021) & (MT)
Table 84. Middle East and Africa Crude Heparin Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Crude Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Crude Heparin Revenue Market Share by Country (2016-2021)
Table 87. Bioiberica Corporation Information
Table 88. Bioiberica Description and Business Overview
Table 89. Bioiberica Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 90. Bioiberica Crude Heparin Product
Table 91. Bioiberica Recent Development
Table 92. Shenzhen Hepalink Corporation Information
Table 93. Shenzhen Hepalink Description and Business Overview
Table 94. Shenzhen Hepalink Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 95. Shenzhen Hepalink Product
Table 96. Shenzhen Hepalink Recent Development
Table 97. Sanofi Corporation Information
Table 98. Sanofi Description and Business Overview
Table 99. Sanofi Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 100. Sanofi Product
Table 101. Sanofi Recent Development
Table 102. Nanjing King-friend Corporation Information
Table 103. Nanjing King-friend Description and Business Overview
Table 104. Nanjing King-friend Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 105. Nanjing King-friend Product
Table 106. Nanjing King-friend Recent Development
Table 107. Fengrun Biological Technology Corporation Information
Table 108. Fengrun Biological Technology Description and Business Overview
Table 109. Fengrun Biological Technology Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 110. Fengrun Biological Technology Product
Table 111. Fengrun Biological Technology Recent Development
Table 112. Aspen Oss Corporation Information
Table 113. Aspen Oss Description and Business Overview
Table 114. Aspen Oss Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 115. Aspen Oss Product
Table 116. Aspen Oss Recent Development
Table 117. Hebei Changshan Biochemical Corporation Information
Table 118. Hebei Changshan Biochemical Description and Business Overview
Table 119. Hebei Changshan Biochemical Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 120. Hebei Changshan Biochemical Product
Table 121. Hebei Changshan Biochemical Recent Development
Table 122. Changzhou Qianhong Corporation Information
Table 123. Changzhou Qianhong Description and Business Overview
Table 124. Changzhou Qianhong Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 125. Changzhou Qianhong Product
Table 126. Changzhou Qianhong Recent Development
Table 127. Hepac (Darling Ingredients) Corporation Information
Table 128. Hepac (Darling Ingredients) Description and Business Overview
Table 129. Hepac (Darling Ingredients) Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 130. Hepac (Darling Ingredients) Product
Table 131. Hepac (Darling Ingredients) Recent Development
Table 132. Huaian MDC Pharmaceutical Corporation Information
Table 133. Huaian MDC Pharmaceutical Description and Business Overview
Table 134. Huaian MDC Pharmaceutical Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 135. Huaian MDC Pharmaceutical Product
Table 136. Huaian MDC Pharmaceutical Recent Development
Table 137. Yantai Dongcheng Biochemicals Corporation Information
Table 138. Yantai Dongcheng Biochemicals Description and Business Overview
Table 139. Yantai Dongcheng Biochemicals Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 140. Yantai Dongcheng Biochemicals Product
Table 141. Yantai Dongcheng Biochemicals Recent Development
Table 142. Crude Heparin Market Trends
Table 143. Crude Heparin Market Drivers
Table 144. Crude Heparin Market Challenges
Table 145. Crude Heparin Market Restraints
Table 146. Crude Heparin Customers List
Table 147. Crude Heparin Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Crude Heparin Product Picture
Figure 2. Global Crude Heparin Sales Market Share by Type in 2020 & 2027
Figure 3. Pig Intestine Mucosa Heparin Product Picture
Figure 4. Bovine Heparin and Others Product Picture
Figure 5. Global Crude Heparin Sales Market Share by Application in 2020 & 2027
Figure 6. Unfractionated Heparin (UFH)
Figure 7. Low-Molecular-Weight Heparin (LMWH)
Figure 8. Crude Heparin Report Years Considered
Figure 9. Global Crude Heparin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Crude Heparin Market Size 2016-2027 (US$ Million)
Figure 11. Global Crude Heparin Sales 2016-2027 (MT)
Figure 12. Global Crude Heparin Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Crude Heparin Sales Market Share by Region (2016-2021)
Figure 14. Global Crude Heparin Sales Market Share by Region in 2020
Figure 15. Global Crude Heparin Revenue Market Share by Region (2016-2021)
Figure 16. Global Crude Heparin Revenue Market Share by Region in 2020
Figure 17. Global Crude Heparin Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Crude Heparin Revenue in 2020
Figure 19. Crude Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Crude Heparin Sales Market Share by Type (2016-2021)
Figure 21. Global Crude Heparin Sales Market Share by Type in 2020
Figure 22. Global Crude Heparin Revenue Market Share by Type (2016-2021)
Figure 23. Global Crude Heparin Revenue Market Share by Type in 2020
Figure 24. Global Crude Heparin Sales Market Share by Application (2016-2021)
Figure 25. Global Crude Heparin Sales Market Share by Application in 2020
Figure 26. Global Crude Heparin Revenue Market Share by Application (2016-2021)
Figure 27. Global Crude Heparin Revenue Market Share by Application in 2020
Figure 28. China Crude Heparin Sales Growth Rate 2016-2027 (MT)
Figure 29. China Crude Heparin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Crude Heparin Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Crude Heparin Players Market Share by Revenue in Crude Heparin in 2020
Figure 32. China Crude Heparin Revenue Share by Type (2016-2021)
Figure 33. China Crude Heparin Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Crude Heparin Revenue Share by Application (2016-2021)
Figure 35. China Crude Heparin Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Crude Heparin Sales Growth Rate 2016-2021 (MT)
Figure 37. North America Crude Heparin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Crude Heparin Sales Market Share by Country in 2020
Figure 39. North America Crude Heparin Revenue Market Share by Country in 2020
Figure 40. U.S. Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 41. U.S. Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 43. Canada Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Crude Heparin Sales Growth Rate 2016-2021 (MT)
Figure 45. Europe Crude Heparin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Crude Heparin Sales Market Share by Country in 2020
Figure 47. Europe Crude Heparin Revenue Market Share by Country in 2020
Figure 48. Germany Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 49. Germany Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 51. France Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 53. U.K. Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 55. Italy Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 57. Russia Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Crude Heparin Sales Growth Rate 2016-2021 (MT)
Figure 59. Asia Pacific Crude Heparin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Crude Heparin Sales Market Share by Region in 2020
Figure 61. Asia Pacific Crude Heparin Revenue Market Share by Region in 2020
Figure 62. China Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 63. China Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 65. Japan Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 67. South Korea Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 69. India Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 71. Australia Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 73. Taiwan Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 75. Indonesia Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 77. Thailand Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 79. Malaysia Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 81. Philippines Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 83. Vietnam Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Crude Heparin Sales Growth Rate 2016-2021 (MT)
Figure 85. Latin America Crude Heparin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Crude Heparin Sales Market Share by Country in 2020
Figure 87. Latin America Crude Heparin Revenue Market Share by Country in 2020
Figure 88. Mexico Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 89. Mexico Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 91. Brazil Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 93. Argentina Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Crude Heparin Sales Growth Rate 2016-2021 (MT)
Figure 95. Middle East and Africa Crude Heparin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Crude Heparin Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Crude Heparin Revenue Market Share by Country in 2020
Figure 98. Turkey Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 99. Turkey Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 101. Saudi Arabia Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE Crude Heparin Sales Growth Rate (2016-2021) (MT)
Figure 103. UAE Crude Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Crude Heparin Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed